{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:20Z","timestamp":1761513800071,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40120-016-0043-7","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T06:54:36Z","timestamp":1460789676000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study"],"prefix":"10.1007","volume":"5","author":[{"given":"Teresa","family":"Ramirez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"Serrano-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Alonso-Morillejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Perea-Justicia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Iglesias-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesif\u00f3n","family":"Parr\u00f3n-Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"43_CR1","doi-asserted-by":"crossref","unstructured":"Sander JW. The use of antiepileptic drugs\u2013principles and practice. Epilepsia. 2004;45 Suppl 6(12):28\u201334.","DOI":"10.1111\/j.0013-9580.2004.455005.x"},{"issue":"4","key":"43_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","volume":"52","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia. 2011;52(4):657\u201378.","journal-title":"Epilepsia"},{"issue":"15","key":"43_CR3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/00019053-200220150-00002","volume":"20","author":"P Berto","year":"2002","unstructured":"Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics. 2002;20(15):1039\u201359.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"43_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.33588\/rn.5608.2013022","volume":"56","author":"V Villanueva","year":"2013","unstructured":"Villanueva V, Serrano-castro PJ. Zonisamida en el tratamiento de la epilepsia: revisi\u00f3n de la bibliograf\u00eda desde la terapia a\u00f1adida a la monoterapia. Rev Neurol. 2013;56(8):429\u201338.","journal-title":"Rev Neurol."},{"key":"43_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1684\/j.1950-6945.2004.tb00075.x","volume":"6","author":"SV Kothare","year":"2004","unstructured":"Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord. 2004;6:267\u201370.","journal-title":"Epileptic Disord"},{"key":"43_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1684\/epd.2009.0239","volume":"11","author":"A Marinas","year":"2009","unstructured":"Marinas A, Villanueva V, Gir\u00e1ldez BG, Molins A, Salas-Puig J, Serratosa JM. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy. Epileptic Disord. 2009;11:61\u20136.","journal-title":"Epileptic Disord"},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2005.02.006","volume":"64","author":"A Wilfong","year":"2005","unstructured":"Wilfong A, Schultz R. Zonisamide for absence seizures. Epilepsy Res. 2005;64:31\u20134.","journal-title":"Epilepsy Res"},{"key":"43_CR8","unstructured":"Chadwick DW, Marson AG. Tratamiento complementario con zonisamida para la epilepsia parcial resistente a f\u00e1rmacos. Biblioteca Cochrane Plus 2008; no. 4. Oxford: Update Software; 2008."},{"key":"43_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yebeh.2015.03.020","volume":"46","author":"B Chen","year":"2015","unstructured":"Chen B, Detyniecki K, Hirsch LJ, Moeller J, Javed A, Kato K, Legge A, Buchsbaum R, Choi H. Cross-sensitivity of patient-perceived adverse cognitive effects with antiepileptic drug use. Epilepsy Behav. 2015;46:151\u20137.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"43_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97\u2013113.","journal-title":"Neuropsychologia"},{"key":"43_CR11","volume-title":"A compendium of neuropsychological test: administration, norms and commentary","author":"O Spreen","year":"1991","unstructured":"Spreen O, Strauss E. A compendium of neuropsychological test: administration, norms and commentary. New York: Oxford UniversityPress; 1991."},{"key":"43_CR12","unstructured":"Wechsler D. Escala de Inteligencia de Wechsler para adultos-III. Manuel de aplicaci\u00f3n y correcci\u00f3n. 3\u00b0 Edici\u00f3n. Madrid: TEA Ediciones, S.A; 2001."},{"key":"43_CR13","volume-title":"Test de copia y de reproducci\u00f3n de memoria de figuras geom\u00e9tricas complejas","author":"A Rey","year":"2003","unstructured":"Rey A. Test de copia y de reproducci\u00f3n de memoria de figuras geom\u00e9tricas complejas. Madrid: TEA Ediciones, S.A; 2003."},{"key":"43_CR14","volume-title":"WMS-III. Escala de memoria de Wechsler-III. Manual de aplicaci\u00f3n y puntuaci\u00f3n","author":"D Wechsler","year":"2004","unstructured":"Wechsler D. WMS-III. Escala de memoria de Wechsler-III. Manual de aplicaci\u00f3n y puntuaci\u00f3n. Madrid: TEA Ediciones, S.A; 2004."},{"key":"43_CR15","volume-title":"Stroop. Test de colores y palabras","author":"CJ Golden","year":"2001","unstructured":"Golden CJ. Stroop. Test de colores y palabras. Madrid: TEA Ediciones, S.A; 2001."},{"key":"43_CR16","volume-title":"Behavioral Assessment of the Dysexecutive Syndrome (BADS)","author":"BA Wilson","year":"1996","unstructured":"Wilson BA, Emslie H, Evans JJ, Burgess PW. Behavioral Assessment of the Dysexecutive Syndrome (BADS). Oxford: Pearson Education Limited; 1996."},{"issue":"4","key":"43_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/arclin\/acp027","volume":"24","author":"J Pe\u00f1a-Casanova","year":"2009","unstructured":"Pe\u00f1a-Casanova J, Blesa R, Aguilar M, Gramunt-Fombuena N, G\u00f3mez-Ans\u00f3n B, Oliva R, Molinuevo JL, Robles A, Barquero MS, Ant\u00fanez C, Mart\u00ednez-Parra C, Frank-Garc\u00eda A, Fern\u00e1ndez M, Alfonso V, Sol JM, NEURONORMA Study Team. Spanish Multicenter Normative Studies (NEURONORMA Project): methods and sample characteristics. Arch Clin Neuropsychol. 2009;24(4):307\u201319.","journal-title":"Arch Clin Neuropsychol."},{"issue":"9","key":"43_CR18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","volume":"11","author":"T Tomson","year":"2012","unstructured":"Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):803\u201313.","journal-title":"Lancet Neurol"},{"issue":"1","key":"43_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yebeh.2009.02.023","volume":"15","author":"G Luef","year":"2009","unstructured":"Luef G. Female issues in epilepsy: a critical review. Epilepsy Behav. 2009;15(1):78\u201382.","journal-title":"Epilepsy Behav"},{"issue":"16","key":"43_CR20","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696\u2013703.","journal-title":"JAMA"},{"issue":"5","key":"43_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(10)70089-2","volume":"9","author":"A Arzimanoglou","year":"2010","unstructured":"Arzimanoglou A, Ryvlin P, Perucca E. When the past challenges the present: are older antiepileptic drugs still the best choice in childhood absence epilepsy? Lancet Neurol. 2010;9(5):457\u20139.","journal-title":"Lancet Neurol"},{"issue":"7","key":"43_CR22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","volume":"56","author":"T Tomson","year":"2015","unstructured":"Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, K\u00e4lvi\u00e4inen R, Trinka E. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia. 2015;56(7):1006\u201319.","journal-title":"Epilepsia."},{"issue":"1","key":"43_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.12603","volume":"22","author":"M Mula","year":"2015","unstructured":"Mula M, Cock HR. More tan seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015;22(1):24\u201330.","journal-title":"Eur J Neurol"},{"issue":"8","key":"43_CR24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/14737175.2015.1065179","volume":"15","author":"A Schulze-Bonhage","year":"2015","unstructured":"Schulze-Bonhage A. The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy. Expert Rev Neurother. 2015;15(8):857\u201365.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"43_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0000000000000246","volume":"35","author":"CM Knapp","year":"2015","unstructured":"Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, et al. Zonisamide, topiramate, and levetiracetam. J Clin Psychopharmacol. 2015;35(1):34\u201342.","journal-title":"J Clin Psychopharmacol."},{"issue":"1","key":"43_CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2007.08.002","volume":"12","author":"SP Park","year":"2008","unstructured":"Park SP, Hwang YH, Lee HW, Suh CK, Kwon SH, Lee BI. Long term cognitive and mood effects of zonisamide monotherapy in epilepsy patients. Epilepsy Behav. 2008;12(1):102\u20138.","journal-title":"Epilepsy Behav"},{"issue":"8","key":"43_CR27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.45.8.1494","volume":"45","author":"KJ Meador","year":"1995","unstructured":"Meador KJ, Loring DW, Moore EE, Thompson WO, Nichols ME, Oberzan RE, Durkin MW, Gallagher BB, King DW. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthyadults. Neurology. 1995;45(8):1494\u20139.","journal-title":"Neurology."},{"issue":"9","key":"43_CR28","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1212\/01.WNL.0000063308.22506.19","volume":"60","author":"KJ Meador","year":"2003","unstructured":"Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R, CAPSS-027 StudyGroup. Differential cognitive and behavioraleffects of topiramate and valproate. Neurology. 2003;60(9):1483\u20138.","journal-title":"Neurology."},{"key":"43_CR29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2015.03.013","volume":"29","author":"A Javed","year":"2015","unstructured":"Javed A, Cohen B, Detyniecki K, Hirsch LJ, Legge A, Chen B, Bazil C, Kato K, Buchsbaum R, Choi H. Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: an extended follow-up. Seizure. 2015;29:34\u201340.","journal-title":"Seizure."},{"issue":"4","key":"43_CR30","first-page":"SS1","volume":"2","author":"KJ Meador","year":"2001","unstructured":"Meador KJ, Gilliam FG, Kanner AM, Pellock JM. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav. 2001;2(4):SS1\u201317.","journal-title":"Epilepsy Behav."},{"issue":"2","key":"43_CR31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mds.23392","volume":"26","author":"D Italiano","year":"2011","unstructured":"Italiano D, Pezzella M, Coppola A, Magaudda A, Ferlazzo E, Bramanti P, Striano S, Zara F, Striano P. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. Mov Disord. 2011;26(2):341\u20133.","journal-title":"Mov Disord."},{"issue":"5","key":"43_CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/WNF.0000000000000046","volume":"37","author":"DW Kim","year":"2014","unstructured":"Kim DW, Choi K, Moon HS, Oh J. Long-term retention rate of zonisamide in patients with epilepsy: an observational study. Clin Neuropharmacol. 2014;37(5):133\u20135.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"43_CR33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1468-1331.2007.02003.x","volume":"15","author":"J Jedrzejczak","year":"2008","unstructured":"Jedrzejczak J, Kunc\u00edkov\u00e1 M, Magureanu S, VIPe Study Group. An observational study of first-line valproate monotherapy in focal epilepsy. Eur J Neurol. 2008;15(1):66\u201372.","journal-title":"Eur J Neurol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-016-0043-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:38:08Z","timestamp":1748893088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40120-016-0043-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s40120-016-0043-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"type":"print","value":"2193-8253"},{"type":"electronic","value":"2193-6536"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}